ISTO Technologies has completed enrollment of its Phase II clinical trial of NuQu, a novel, cell-based therapy for the treatment of pain and disability associated with degenerated spinal discs. The company has completed enrollment of 44 ...
Tags: ISTO Technologies, Back Pain Study